Roche diagnostics corp:1106277 [13-013529]
Ended Awarded
- Contract number
- HHSN26900001
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Chief Operating Officer
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,525
Award facts
- Contract value 100% obligated
- $6,525.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which is a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price (FFP) pricing type, has a ceiling value of $6,525.40 and was awarded on August 2, 2013 by the Office of the Chief Operating Officer, a civilian federal agency. The contract does not have a set-aside designation, indicating Roche Diagnostics competed openly for the award. The contract is for the provision of medical diagnostic technologies, including equipment, testing systems, reagents, and clinical testing services, to support federal healthcare agencies such as the Department of Veterans Affairs (VA), Defense Health Agency, and Centers for Disease Control and Prevention. Roche Diagnostics is a global leader in diagnostic solutions and holds multiple significant Indefinite Delivery Contracts (IDCs) and BPAs across various federal agencies, often leveraging General Services Administration (GSA) Schedule contracts to facilitate efficient procurement of its products and services.
Quick answers
Who was awarded contract HHSN26900001?
HHSN26900001 was awarded to Roche Diagnostics Corporation by Office of the Chief Operating Officer (National Institutes of Health) on August 2, 2013.
How much is contract HHSN26900001 worth?
The government has obligated $6,525 on HHSN26900001.
Is contract HHSN26900001 an order under another contract?
Yes. HHSN26900001 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26900001 competed?
The extent of competition for HHSN26900001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award